Nabumetone
Product Images NDC 61919-609

3 FDA label images from Direct Rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 61919-609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

609 60

609 60
NABUMETONE 500 mg tablet bottle label for 60 tablets, distributed by DIRECT RX. The label identifies the product as a generic for RELAFEN containing Nabumetone USP 500 mg per tablet. Additional details include lot number, discard after date 07/20, storage instructions, and warnings about possible drowsiness or dizziness.*
FDA Label Image

60 (636 60)

60 (636 60)
Packaging label for Duloxetine D/R 20 mg capsules, 60 count. The label states it is a generic for Cymbalta, with each delayed-release capsule containing 22.4 mg of duloxetine hydrochloride USP equivalent to 20 mg duloxetine. Distributed by Direct RX in Alpharetta, GA. The package includes warnings about drowsiness or dizziness, with advice on medication use and potential side effects.*
FDA Label Image

30 (668 30)

30 (668 30)
NABUMETONE 500mg tablet box label displaying the product name, strength, and quantity of 30 tablets. The label indicates the generic for Relafen and each tablet contains nabumetone USP 500mg. It shows the labeler as Direct Rx and includes packaging, lot number, and discard date information along with warnings about drowsiness or dizziness.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.